Harbin Novartis Biopharmaceutical Co., Ltd. was established in March 2016, specializing in the application, development and production of dihydroquercetin. The company has a professional R&D team composed of 5 doctors and more than 10 masters, and has close cooperation with Peking University and Harbin Medical University in the field of technology research and development. With professional extraction technology with independent intellectual property rights, product extraction has been certified by the internationally renowned testing organization Pony for non-toxic and residue-free green testing.